Free Trial

Siga Technologies (SIGA) Competitors

Siga Technologies logo
$8.99 -0.01 (-0.11%)
Closing price 09/16/2025 04:00 PM Eastern
Extended Trading
$8.99 +0.00 (+0.06%)
As of 07:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SIGA vs. IDYA, OCUL, MLYS, IBRX, DNLI, IRON, BEAM, CNTA, BLTE, and AGIO

Should you be buying Siga Technologies stock or one of its competitors? The main competitors of Siga Technologies include IDEAYA Biosciences (IDYA), Ocular Therapeutix (OCUL), Mineralys Therapeutics (MLYS), ImmunityBio (IBRX), Denali Therapeutics (DNLI), Disc Medicine (IRON), Beam Therapeutics (BEAM), Centessa Pharmaceuticals (CNTA), Belite Bio (BLTE), and Agios Pharmaceuticals (AGIO). These companies are all part of the "pharmaceutical products" industry.

Siga Technologies vs. Its Competitors

IDEAYA Biosciences (NASDAQ:IDYA) and Siga Technologies (NASDAQ:SIGA) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations.

Siga Technologies has a net margin of 45.73% compared to IDEAYA Biosciences' net margin of 0.00%. Siga Technologies' return on equity of 40.52% beat IDEAYA Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
IDEAYA BiosciencesN/A -31.42% -29.45%
Siga Technologies 45.73%40.52%35.62%

Siga Technologies has higher revenue and earnings than IDEAYA Biosciences. IDEAYA Biosciences is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IDEAYA Biosciences$7M309.49-$274.48M-$3.79-6.52
Siga Technologies$138.72M4.64$59.21M$1.137.96

IDEAYA Biosciences has a beta of 0.12, meaning that its stock price is 88% less volatile than the S&P 500. Comparatively, Siga Technologies has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500.

IDEAYA Biosciences presently has a consensus price target of $42.85, suggesting a potential upside of 73.33%. Given IDEAYA Biosciences' stronger consensus rating and higher possible upside, equities analysts clearly believe IDEAYA Biosciences is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IDEAYA Biosciences
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.81
Siga Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, IDEAYA Biosciences had 17 more articles in the media than Siga Technologies. MarketBeat recorded 19 mentions for IDEAYA Biosciences and 2 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 0.95 beat IDEAYA Biosciences' score of 0.46 indicating that Siga Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IDEAYA Biosciences
2 Very Positive mention(s)
6 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Siga Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

98.3% of IDEAYA Biosciences shares are held by institutional investors. Comparatively, 55.4% of Siga Technologies shares are held by institutional investors. 2.5% of IDEAYA Biosciences shares are held by insiders. Comparatively, 2.0% of Siga Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Siga Technologies beats IDEAYA Biosciences on 9 of the 16 factors compared between the two stocks.

Get Siga Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SIGA vs. The Competition

MetricSiga TechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$644.45M$2.55B$5.73B$10.31B
Dividend YieldN/A60.31%5.90%4.63%
P/E Ratio7.9623.4976.3826.51
Price / Sales4.64672.77521.37123.58
Price / Cash10.76169.4937.1760.46
Price / Book2.985.3313.666.29
Net Income$59.21M$32.95M$3.28B$270.51M
7 Day Performance3.10%0.10%0.88%1.95%
1 Month Performance5.76%3.91%4.67%6.33%
1 Year Performance14.09%-3.91%80.92%25.62%

Siga Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SIGA
Siga Technologies
1.4314 of 5 stars
$8.99
-0.1%
N/A+12.5%$644.45M$138.72M7.9640
IDYA
IDEAYA Biosciences
3.9625 of 5 stars
$23.39
-13.9%
$45.77
+95.7%
-32.9%$2.38B$7M-6.1780High Trading Volume
OCUL
Ocular Therapeutix
3.9008 of 5 stars
$12.71
-6.5%
$17.20
+35.3%
+39.3%$2.37B$63.72M-9.93230Positive News
Analyst Forecast
MLYS
Mineralys Therapeutics
2.9191 of 5 stars
$35.93
+3.2%
$36.60
+1.9%
+222.6%$2.31BN/A-10.0928Insider Trade
IBRX
ImmunityBio
2.5161 of 5 stars
$2.41
+0.4%
$10.75
+346.1%
-19.5%$2.27B$14.74M-5.02590
DNLI
Denali Therapeutics
4.2948 of 5 stars
$15.50
+0.5%
$33.62
+116.9%
-56.3%$2.26B$330.53M-5.54430Positive News
IRON
Disc Medicine
3.2339 of 5 stars
$61.91
+1.9%
$98.30
+58.8%
+26.6%$2.11BN/A-13.8530Positive News
High Trading Volume
BEAM
Beam Therapeutics
3.182 of 5 stars
$19.94
-4.5%
$48.45
+143.0%
-10.6%$2.11B$63.52M-4.43510Analyst Downgrade
CNTA
Centessa Pharmaceuticals
3.1287 of 5 stars
$18.03
+14.6%
$31.45
+74.5%
+29.6%$2.11B$6.85M-10.07200Insider Trade
High Trading Volume
BLTE
Belite Bio
2.5175 of 5 stars
$67.51
+2.7%
$96.67
+43.2%
+37.3%$2.09BN/A-43.5510Trending News
Analyst Forecast
Analyst Revision
Gap Up
AGIO
Agios Pharmaceuticals
4.314 of 5 stars
$36.41
+1.1%
$56.00
+53.8%
-19.1%$2.09B$40.88M3.31390

Related Companies and Tools


This page (NASDAQ:SIGA) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners